Literature DB >> 316207

Lung distensibility and airway function in intermediate alpha 1-antitrypsin deficiency (Pi MZ).

S F Tattersall, R P Pereira, D Hunter, G Blundell, N B Pride.   

Abstract

We examined the role of intermediate alpha 1-antitrypsin deficiency in predisposing to abnormalities of lung distensibility and airway function in 20 heterozygotes (Pi MZ) who were individually matched with a control Pi M subject of similar age, height, and smoking habits drawn from the same male, working population. There were no significant differences between the heterozygotes and their controls in the results of spirometry, maximum expiratory flow-volume curves (breathing air), single breath nitrogen test, arterialised capillary blood oxygen pressure, or single breath carbon monoxide transfer. Additional studies were made in 12 of the pairs of Pi MZ and Pi M subjects. Comparison of maximum expiratory flow-volume curves breathing air and 80% helium-20% oxygen showed no differences between the Pi MZ and Pi M subjects. Although airway function was similar in the two groups, four of 12 Pi MZ subjects showed abnormalities of the pressure-volume curve of the lung (reduction in lung recoil pressure, abnormal shape factor, increase in functional residual capacity). Abnormalities of washout of a helium-sulphur hexafluoride gas mixture, of a type previously described as characteristic of emphysema, were found in two of the men with abnormal pressure-volume curves. The results suggest that Pi MZ subjects have an increased susceptibility to alveolar abnormalities without increased abnormalities of airway function; this may explain the increased frequency of emphysema at necropsy despite many studies showing no predisposition to abnormal airway function in life. The functional changes we observed would be unlikely to cause symptoms. The risk of disablement from chronic lung disease appears to be only slightly enhanced by intermediate alpha 1-antitrypsin deficiency.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 316207      PMCID: PMC471138          DOI: 10.1136/thx.34.5.637

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  35 in total

1.  Smoking and intermediate alpha1-antitrypsin deficiency and lung function in middle-aged men.

Authors:  C Larsson; S Eriksson; H Dirksen
Journal:  Br Med J       Date:  1977-10-08

2.  [Pulmonary abnormality and alpha 1-antitrypsin heterozygote deficiency in a working population (author's transl)].

Authors:  F Girard; F Aug; M Camara; A B Bohadana; A Bagrel; G Museur; S Abraham
Journal:  Bull Eur Physiopathol Respir       Date:  1978 Jan-Feb

3.  [Alpha 1-antitrypsin deficiency and its repercussions in pulmonary pathophysiology (author's transl)].

Authors:  M Camara; J P Martin
Journal:  Bull Eur Physiopathol Respir       Date:  1978 Jan-Feb

4.  Relation of protease inhibitor phenotypes to obstructive lung diseases in a community.

Authors:  J O Morse; M D Lebowitz; R J Knudson; B Burrows
Journal:  N Engl J Med       Date:  1977-05-26       Impact factor: 91.245

5.  Closing volume and flow volume abnormalities in alpha(1)-antitrypsin phenotype groups in a community population.

Authors:  M D Lebowitz; R J Knudson; J O Morse; D Armet
Journal:  Am Rev Respir Dis       Date:  1978-01

6.  Heterozygous alpha-1-antitrypsin deficiency and respiratory function in children.

Authors:  J C Vance; W J Hall; R H Schwartz; R W Hyde; K J Roghmann; G C Mudholkar
Journal:  Pediatrics       Date:  1977-09       Impact factor: 7.124

7.  Intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease in Yugoslavia.

Authors:  D Kozarevic; M Laban; M Budimir; N Vojvodic; A Roberts; T Gordon; D L McGee
Journal:  Am Rev Respir Dis       Date:  1978-06

8.  Assessment of alpha-1-antitrypsin deficiency heterozygosity as a risk factor in the etiology of emphysema. Physiological comparison of adult normal and heterozygous protease inhibitor phenotype subjects from a random population.

Authors:  D J McDonagh; S P Nathan; R J Knudson; M D Lebowitz
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

9.  Liver, lung and malignant disease in heterozygous (Pi MZ) alpha1-antitrypsin deficiency.

Authors:  S Eriksson; T Moestrup; I Hägerstrand
Journal:  Acta Med Scand       Date:  1975-10

10.  Emphysema with minor airway obstruction and abnormal tests of small airway disease.

Authors:  M Demedts; J Cosemans; M De Roo; L Billiet; K P van de Woestijne
Journal:  Respiration       Date:  1978       Impact factor: 3.580

View more
  5 in total

1.  Respiratory symptoms and pulmonary function in 871 miners according to Pi phenotype: a longitudinal study.

Authors:  F Pierre; Q T Pham; J M Mur; N Chau; J P Martin
Journal:  Eur J Epidemiol       Date:  1988-03       Impact factor: 8.082

2.  Use of lung pressure-volume curves and helium-sulphur hexafluoride washout to detect emphysema in subjects with mild airflow obstruction.

Authors:  R P Pereira; D Hunter; N B Pride
Journal:  Thorax       Date:  1981-01       Impact factor: 9.139

Review 3.  Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis.

Authors:  C P Hersh; M Dahl; N P Ly; C S Berkey; B G Nordestgaard; E K Silverman
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

4.  A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema.

Authors:  Irina Petrache; Iwona Fijalkowska; Lijie Zhen; Terry R Medler; Emile Brown; Pedro Cruz; Kang-Hyeon Choe; Laimute Taraseviciene-Stewart; Robertas Scerbavicius; Lee Shapiro; Bing Zhang; Sihong Song; Dan Hicklin; Norbert F Voelkel; Terence Flotte; Rubin M Tuder
Journal:  Am J Respir Crit Care Med       Date:  2006-03-02       Impact factor: 21.405

Review 5.  Environmental and genetic risk factors and gene-environment interactions in the pathogenesis of chronic obstructive lung disease.

Authors:  R Walter; D J Gottlieb; G T O'Connor
Journal:  Environ Health Perspect       Date:  2000-08       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.